These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18189068)

  • 1. Nodular basal cell carcinoma: when in doubt, cut it out.
    Brownell I
    J Drugs Dermatol; 2007 Dec; 6(12):1245-6. PubMed ID: 18189068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream.
    Devirgiliis V; Panasiti V; Curzio M; Gobbi S; Rossi M; Roberti V; Calvieri S
    Dermatol Online J; 2008 Feb; 14(2):25. PubMed ID: 18700128
    [No Abstract]   [Full Text] [Related]  

  • 3. Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream.
    Requena C; Messeguer F; Llombart B; Serra-Guillén C; Guillén C
    Int J Dermatol; 2012 Apr; 51(4):451-4. PubMed ID: 22435437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
    Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
    J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison in real clinical practice of methyl aminolevulinate photodynamic therapy and surgery for small superficial basal cell carcinoma: 3-year recurrence rates and cosmetic outcomes.
    Sebaratnam DF; Venugopal SS; Murrell DF
    J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):117-8. PubMed ID: 20456551
    [No Abstract]   [Full Text] [Related]  

  • 6. [Periocular basal cell carcinoma treatment tendencies].
    García Martín E; Fernández Tirado FJ
    Arch Soc Esp Oftalmol; 2010 Aug; 85(8):261-2. PubMed ID: 21130940
    [No Abstract]   [Full Text] [Related]  

  • 7. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas.
    Nikkels AF; Piérard-Franchimont C; Nikkels-Tassoudji N; Bourguignon R; Piérard GE
    Acta Clin Belg; 2005; 60(5):227-34. PubMed ID: 16398319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.
    Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K
    Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.
    Szeimies RM
    Dermatol Clin; 2007 Jan; 25(1):89-94. PubMed ID: 17126746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial.
    Rhodes LE; de Rie M; Enström Y; Groves R; Morken T; Goulden V; Wong GA; Grob JJ; Varma S; Wolf P
    Arch Dermatol; 2004 Jan; 140(1):17-23. PubMed ID: 14732655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
    Itkin A; Gilchrest BA
    Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities.
    Aguilar M; de Troya M; Martin L; Benítez N; González M
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1431-6. PubMed ID: 20456549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Basal cell carcinoma].
    Takenouchi T
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1398-403. PubMed ID: 17033227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential treatment of giant basal cell carcinomas.
    Madan V; West CA; Murphy JV; Lear JT
    J Plast Reconstr Aesthet Surg; 2009 Oct; 62(10):e368-72. PubMed ID: 18572004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminolevulinic acid photodynamic therapy for skin cancers.
    Blume JE; Oseroff AR
    Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma.
    Cosgarea R; Susan M; Crisan M; Senila S
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):980-4. PubMed ID: 22738399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome.
    Wolfe CM; Green WH; Hatfield HK; Cognetta AB
    J Drugs Dermatol; 2012 Nov; 11(11):1364-5. PubMed ID: 23135091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial'.
    Nijsten T
    Br J Dermatol; 2015 Jan; 172(1):12. PubMed ID: 25581586
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma.
    Arits AH; Spoorenberg E; Mosterd K; Nelemans P; Kelleners-Smeets NW; Essers BA
    Br J Dermatol; 2014 Dec; 171(6):1501-7. PubMed ID: 24749843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal'.
    Arits A; Nelemans P; Kelleners-Smeets N
    Br J Dermatol; 2015 Jan; 172(1):11-2. PubMed ID: 25581585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.